Izotropic (IZO) Price & Analysis

Compare

15 Followers

IZO Stock Chart & Stats

C$0.28

C$0.01(8.33%)

At close: Jan 08 4:00 PM EST

C$0.28

C$0.01(8.33%)

Day’s Range― - ―

52-Week RangeC$0.19 - C$0.49

Previous CloseN/A

Volume236.24K

Average Volume (3M)43.33K

Market Cap

C$16.61M

Enterprise ValueC$17.31M

Total Cash (Recent Filing)C$229.86K

Total Debt (Recent Filing)C$2.97M

Price to Earnings (P/E)―

Beta-0.15

Next Earnings

Mar 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding67,784,676

10 Day Avg. Volume24,438

30 Day Avg. Volume43,328

Financial Highlights & Ratios

PEG Ratio-0.05

Price to Book (P/B)-2.90

Price to Sales (P/S)0.00

P/FCF Ratio-22.10

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Dedicated Breast CT ProductIzoView is a dedicated 3D breast CT platform focused on screening and diagnostic imaging. A single, differentiated product offering allows focused R&D and regulatory efforts, a clearer go-to-market plan, and the potential to establish a niche competitive position in breast imaging over the coming months.

Improving Cash Burn TrendThe cash flow summary notes a positive TTM free cash flow growth rate versus the prior period, signalling reduced burn. Sustained improvement in cash consumption can materially extend runway, lower near-term financing frequency, and give management time to advance clinical and regulatory milestones.

Targets Stable Clinical NeedThe technology is positioned for breast cancer screening and diagnostic imaging, a steady and clinically essential market. Addressing a persistent healthcare need supports durable demand potential and long-term relevance for a novel imaging modality if clinical adoption progresses.

Bears Say

No Revenue; Ongoing LossesTTM results show no revenue and continued operating losses (EBIT ~-2.5M; net loss ~-2.7M). Persistent lack of product revenue means the business is not self-sustaining, increasing dependence on external capital and raising execution risk for commercialization and regulatory milestones.

Negative Equity; Small Asset BaseThe balance sheet is strained with negative shareholders' equity (~-5.5M), a very small asset base (~0.45M) and meaningful debt (~3.0M). Negative equity elevates solvency risk, constrains borrowing capacity, and makes the company more likely to need dilutive financing to fund operations or commercialization.

Negative Operating And Free Cash FlowOperating and free cash flow remain negative in the TTM (~-1.0M), indicating ongoing cash burn and reliance on external funding despite burn improvements. Continued negative cash flows limit ability to invest in scaling, may delay milestones, and increase funding risk over the next several months.

Izotropic News

Izotropic Moves to Establish African and GCC Hub for Breast CT Imaging

Izotropic ( ($TSE:IZO) ) has issued an update. Izotropic Corporation has signed a letter agreement with a business...

4d ago

Izotropic Raises Working Capital and Settles Debt with Equity Units

Izotropic ( ($TSE:IZO) ) has issued an update. Izotropic closed a $300,000 non-brokered private placement by issuing 1.2 million...

19d ago

Izotropic Plans $300,000 Private Placement to Advance IzoView Breast CT Commercialization

Izotropic ( ($TSE:IZO) ) has shared an announcement. Izotropic Corporation has provided a corporate update outlining its strategic...

25d ago

Izotropic Shareholders Approve All AGM Resolutions and Lower Quorum Threshold

Izotropic ( ($TSE:IZO) ) has provided an announcement. Izotropic Corporation reported that all resolutions presented at its Annual...

2M ago

Izotropic Corporation Announces Debt Settlement Agreement

Izotropic ( ($TSE:IZO) ) has shared an update. Izotropic Corporation has entered into a debt settlement agreement to...

3M ago

Izotropic Corporation Announces Debt Settlement Agreement

The latest announcement is out from Izotropic ( ($TSE:IZO) ). Izotropic Corporation has entered into a debt settlement...

3M ago

Izotropic Expands AI Integration in Breast Imaging with New Podcast Episode

The latest announcement is out from Izotropic ( ($TSE:IZO) ). Izotropic Corporation has released the second episode of...

3M ago

Izotropic Enhances Educational Outreach with New ‘Breast Imaging News’ Page

The latest announcement is out from Izotropic ( ($TSE:IZO) ). Izotropic Corporation has launched a ‘Breast Imaging News’...

4M ago

Izotropic Unveils Strategic Plans for IzoView Breast CT Platform

Izotropic ( ($TSE:IZO) ) has issued an announcement. Izotropic Corporation has released a video interview with CEO Bob...

4M ago

Izotropic Highlights IzoView’s AI-Driven Imaging Advantage

Izotropic ( ($TSE:IZO) ) has shared an update. Izotropic Corporation has announced a new feature article on BreastCT.com,...

5M ago

IZO FAQ

What was Izotropic Corp.’s price range in the past 12 months?

Izotropic Corp. lowest stock price was C$0.19 and its highest was C$0.49 in the past 12 months.

What is Izotropic Corp.’s market cap?

Izotropic Corp.’s market cap is C$16.61M.

When is Izotropic Corp.’s upcoming earnings report date?

Izotropic Corp.’s upcoming earnings report date is Mar 26, 2026 which is in 31 days.

How were Izotropic Corp.’s earnings last quarter?

Izotropic Corp. released its earnings results on Dec 30, 2025. The company reported -C$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.012.

Is Izotropic Corp. overvalued?

According to Wall Street analysts Izotropic Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Izotropic Corp. pay dividends?

Izotropic Corp. does not currently pay dividends.

What is Izotropic Corp.’s EPS estimate?

Izotropic Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Izotropic Corp. have?

Izotropic Corp. has 67,784,676 shares outstanding.

What happened to Izotropic Corp.’s price movement after its last earnings report?

Izotropic Corp. reported an EPS of -C$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.754%.

Which hedge fund is a major shareholder of Izotropic Corp.?

Currently, no hedge funds are holding shares in TSE:IZO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Izotropic Corp.

Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.